IL6 and atherosclerosis: These pathways can promote the release of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which have been shown to contribute to endothelial dysfunction and atherosclerosis [42].